National Cancer Institute National Cancer Institute
U.S. National Institutes of Health National Cancer Institute
NCI Home Cancer Topics Clinical Trials Cancer Statistics Research & Funding News About NCI
NCI's Clinical Trials Reporting Program




Introduction






Timeline






Contact Us



Page Options
Print This Page  Print This Page
Print This Document  Print This Document
View Entire Document  View Entire Document
E-Mail This Document  E-Mail This Document
Quick Links
Director's Corner

Dictionary of Cancer Terms

NCI Drug Dictionary

Funding Opportunities

NCI Publications

Advisory Boards and Groups

Science Serving People

Español
NCI Highlights
High Dose Chemotherapy Prolongs Survival for Leukemia

Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E

Past Highlights
Introduction

NCI's new Clinical Trials Reporting Program (CTRP) fulfills a recommendation made by the NCI Clinical Trials Working Group (CTWG) NCI Clinical Trials Working Group (CTWG) to the National Cancer Advisory Board.

The purpose of the program is to establish a comprehensive database containing regularly updated information on all NCI funded interventional clinical trials. Grantees will be requested to enter specific information about each clinical trial into the database. NCI will use this information to coordinate research efforts to optimize our nation's investment in cancer research.

NCI will begin a phased launch of CTRP starting January 2009 that will initially focus on registering interventional trials only. The registration of observational, ancillary and correlative studies will begin in 2010.

Check back regularly for updates.

Back to TopBack to Top

Next Section >


A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov